Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000235892

Medchemexpress LLC Bozitinib (PLB-1001) | 1440964-89-5 | 98.9% | 424.38 g/mol | C20H15F3N8 | 100MG
SDP

Supplier:  Medchemexpress LLC HY125017100MG

Encompass_Preferred

Bozitinib (PLB-1001) is a selective, ATP-competitive small-molecule inhibitor of the c-MET (HGFR) tyrosine kinase with demonstrated blood-brain barrier permeability. Supplied for research use in multiple formats and sizes, it is intended for in vitro and preclinical studies of MET-driven oncogenic signaling and kinase pharmacology.

  • Selective c-MET kinase inhibition for MET-driven research.
  • ATP-competitive mechanism of action.
  • Demonstrated blood-brain barrier permeability.
  • Available as solid or DMSO solution formats for assay flexibility.
  • High purity suitable for biochemical and cellular assays.
  • Documented molecular formula and molecular weight for analytical reference.

Catalog No. 50-002-35892


May include imposed supplier surcharges.
Only null left
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.